Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
4.580
-0.220 (-4.58%)
At close: Jun 5, 2026, 4:00 PM EDT
4.990
+0.410 (8.95%)
After-hours: Jun 5, 2026, 7:58 PM EDT
Shattuck Labs Employees
Shattuck Labs had 40 employees as of December 31, 2025. The number of employees decreased by 4 or -9.09% compared to the previous year.
Employees
40
Change (1Y)
-4
Growth (1Y)
-9.09%
Revenue / Employee
$25,000
Profits / Employee
-$1,246,850
Market Cap
351.20M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 40 | -4 | -9.09% |
| Dec 31, 2024 | 44 | -31 | -41.33% |
| Dec 31, 2023 | 75 | -30 | -28.57% |
| Dec 31, 2022 | 105 | 20 | 23.53% |
| Dec 31, 2021 | 85 | 26 | 44.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Enanta Pharmaceuticals | 120 |
| Artiva Biotherapeutics | 104 |
| Verastem | 102 |
| OmniAb | 89 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| Atea Pharmaceuticals | 55 |
STTK News
- 16 hours ago - Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a Potentially First-in-Class DR3 Blocking Antibody, and Pipeline Update on June 8 - GlobeNewsWire
- 1 day ago - Citi opens ‘upside 30-day catalyst watch’ on Shattuck into data - TheFly
- 1 day ago - Shattuck Labs upgraded to Buy from Neutral at Citi - TheFly
- 4 weeks ago - Shattuck Labs price target raised to $11 from $8 at Wedbush - TheFly
- 4 weeks ago - Shattuck Labs reports Q1 EPS (13c), consensus (13c) - TheFly
- 4 weeks ago - Shattuck Labs sees cash and cash equivalents sufficient into 2029 - TheFly
- 4 weeks ago - Shattuck Labs Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Shattuck Labs Earnings release: Q1 2026 - Filings